Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was founded in 2016 and is headquartered in Seattle, Washington.
History
Nautilus Biotechnology was established in 2015 by a team of world-leading experts in biology, engineering, AI and software. In 2016, the company closed a $2M seed round of financing. Nautilus is located in Seattle, Washington.
Mission
Our mission is to revolutionize the effectiveness and reliability of proteomics applications in biomedical science and biotechnology.
Vision
Our vision is to create a platform that enables researchers and clinicians to uncover the full potential of protein-based therapeutics.
